Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Are The Market Size Estimates For The Genomic Urine Testing Market?

Rapid expansion has been a defining factor of the genomic urine testing market in the recent past. A predicted growth from $0.9 billion in 2024 to $1.01 billion in 2025, marked by a compound annual growth rate (CAGR) of 11.9%, further reflects this pattern. Several factors have informed this historic hike. They include a rising instance of urologic cancers, an escalating interest in early cancer detection, mounting consciousness around precision medicine, an advancing rate of genetic disorders, and expanding investments poured into biomarker discovery.

The market size of genomic urine testing is set to experience a swift expansion in the upcoming years, predicted to reach $1.61 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 12.4%. Factors driving this growth during the prediction period include the growing implementation of liquid biopsy methods, an increased interest in personalized healthcare, an escalating incidence of chronic kidney ailments, a greater focus on at-home diagnostic tests, and a rising application of multi-omics methods in urine testing. Notable trends in the prediction period comprise the evolution of non-invasive diagnostic paths, creation of high-sensitivity test panels, incorporation of machine learning workflows, advancements in urine exosome segregation, and innovation surrounding single-cell urine sequencing.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=23408&type=smp

Which Growth Drivers Are Shaping The Genomic Urine Testing Market Outlook?

The escalating prevalence of chronic kidney disease is anticipated to stimulate the genomic urine testing market’s expansion. This disease is typified by kidney damage rendering them incapable of filtering blood effectively, hence resulting in waste and fluid accumulation in the body. The rise in diabetes instances, leading to high blood sugar levels that damage kidney blood vessels and hamper their waste filtration capability, are augmenting the burden of chronic kidney disease. Genomic urine testing proves beneficial in managing chronic kidney disease by allowing for early identification of distinct genetic markers and facilitating timely interventions and custom-tailored treatment strategies. It improves patient outcomes by allowing for more precise monitoring and curtailing disease advancement. For instance, the Australian Institute of Health and Welfare, a government agency based in Australia, reported in June 2024 that the mortality rates for chronic kidney disease (CKD) increased from 4.2% in 2021 to 6.2% in 2022. Thus, the escalating prevalence of chronic kidney disease fuels the expansion of the genomic urine testing market.

What Are The Primary Segmentation Parameters In The Genomic Urine Testing Market?

The genomic urine testingmarket covered in this report is segmented –

1) By Testing Type: Deoxyribonucleic Acid (DNA) Testing; Ribonucleic Acid (RNA) Testing; Microbial Testing; Epigenetic Testing

2) By Distribution Channel: Hospital Pharmacies; Mail Order Pharmacies; Speciality Pharmacies

3) By Application: Cancer Diagnosis; Infectious Diseases; Genetic Disorder Screening; Health Monitoring

4) By End-User: Hospitals And Clinics; Diagnostic Laboratories; Research And Academic Institutions; Other End Users

Subsegments:

1) By Deoxyribonucleic Acid Testing: Germline Mutation Analysis; Somatic Mutation Detection; Copy Number Variation (CNV) Testing; Single Nucleotide Polymorphism Analysis

2) By Ribonucleic Acid Testing: Gene Expression Profiling; Messenger Ribonucleic Acid Analysis; Non-coding Ribonucleic Acid Detection; Fusion Transcript Detection

3) By Microbial Testing: Urinary Microbiome Profiling; Pathogen Identification; Antimicrobial Resistance Gene Detection; Quantitative Microbial Load Analysis

4) By Epigenetic Testing: Deoxyribonucleic Acid Methylation Analysis; Histone Modification Profiling; Chromatin Accessibility Testing

How Are Market Trends Influencing Competition In The Genomic Urine Testing Market?

Leading businesses in the genomic urine testing market are concentrating on the creation of ground-breaking solutions, namely next-generation sequencing, to bolster the precision, sensitivity, and speed of early detection for non-invasive diagnostic tests used for various illnesses. The technique of next-generation sequencing (NGS) is a more evolved method of DNA sequencing that supports swift, detailed, and large-scale assessments of genetic materials by sequencing millions of DNA fragments all at once. For example, Convergent Genomics Inc., a biotech company from the US, introduced in May 2023, the UroAmp, a genomic urine test. This test used the novel DNA sequencing technique for examining alterations in 60 genes linked to bladder cancer, facilitating early detection of up to 12 years ahead of clinical symptom development. It offers comprehensive genetic perspectives which aid diagnosis, informs treatment choices, and monitors recurrence, proving more precise than conventional techniques such as cytology and cystoscopy.

Which Organizations Are At The Forefront Of The Genomic Urine Testing Market?

Major companies operating in the genomic urine testing market are Eurofins Scientific SE, Thermo Fisher Scientific, Abbott Laboratories, Laboratory Corporation of America Holdings, Hologic Inc., Illumina Inc., Myriad Genetics Inc., ARUP Laboratories, MedGenome Labs Ltd, GENETWORx LLC, MDxHealth SA, Nucleix Ltd., ​Pacific Edge Ltd, Convergent Genomics Inc., LynxDx Inc., miR Scientific, RYND Biotech, UGenDx Ltd

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/genomic-urine-testing-global-market-report

Which Region Holds The Greatest Opportunity For Genomic Urine Testing Market Expansion?

North America was the largest region in the genomic urine testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genomic urine testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=23408&type=smp

Browse Through More Reports Similar to the Global Genomic Urine Testing Market 2025, By The Business Research Company

Agrigenomics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/agrigenomics-global-market-report

Ai In Genomics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/ai-in-genomics-global-market-report

Blockchain In Genomics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blockchain-in-genomics-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model